semaglutide malnutrition Awareness Week: The Role of Nutrition in Surgery Eating Too Little on Semaglutide:

Injection site reactions (erythema, edema, mild discomfort) occur in 815% of reported cases and typically resolve within 13 days

The earlier of these two dates determines when to stop using the vial

The FDA recently declared NMN an investigational drug , not a dietary supplement

This property makes it crucial for specific medical and laboratory purposes where sterility and dosing precision are imperative

Case reports in the medical literature describe women who unknowingly continued injections for 1-2 weeks after conception without reported adverse fetal outcomes, though long-term follow-up data remains sparse

future studies will shed light on whether semaglutide can compete (or synergize) with non-GLP-1 drugs like resmetirom (Madrigal, 30% resolution at 52 weeks), efuxifermin (Akero) and Lanifibranor (Inventiva) that are in late stage clinical testing for NASH